2017. Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis. Biomolecules and Biomedicine. 17, 4 (Nov. 2017), 302–308. DOI:https://doi.org/10.17305/bjbms.2017.1938.